Cancer research has revealed that KCNJ15, as a differentially expressed gene, correlates with the clinical prognosis of renal cancer, esophageal squamous cell carcinoma, breast cancer, and glioma (Table 1). Here, KCNJ15 is linked to breast carcinoma.